GlassScriptPhysician profile
Joseph Anthony Bisignaro
NPI 1457367237
$1,172.26
in general payments reported to CMS, 2019-2025
17 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $96.81 · 2021: $398 · 2022: $85.01 · 2023: $29.54 · 2024: $20.06 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $242.36 | 2021-2025 | |
| Misonix INC | $230.98 | 2019-2021 | |
| Smith+Nephew, INC. | $201.60 | 2019-2025 | Collagenase Santyl |
| Depuy Synthes Sales INC. | $64.57 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $63.41 | 2020 | |
| Stryker Corporation | $51.85 | 2019-2023 | Infinity |
| Eclipse Technology Solutions INC. | $46.43 | 2024-2025 | |
| Sebela Pharmaceuticals INC. | $39.47 | 2019 | |
| Djo, LLC | $37.16 | 2019 | |
| Liberty Surgical INC. | $36.18 | 2021 | |
| Organogenesis INC. | $36.17 | 2019-2020 | |
| Averitas Pharma INC. | $35.01 | 2025 | Qutenza |
| Merck Sharp & Dohme LLC | $26.29 | 2019 | |
| Orthofix Medical, INC. | $23.24 | 2025 | Physio-Stim |
| Integra Lifesciences Corporation | $18.95 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $11.10 | 2022 | |
| Lifenet Health | $7.49 | 2025 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Bisignaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.